Acknowledgement
Supported by : 대한우울.조울병학회, 대한정신약물학회
References
- Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002;68:167-181. https://doi.org/10.1016/S0165-0327(01)00377-9
- McIntyre RS, Rosenbluth M, Ramasubbu R, Bond DJ, Taylor VH, Beaulieu S, et al. Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder. Ann Clin Psychiatry 2012;24:163-169.
- Gurpegui M, Martinez-Ortega JM, Gutierrez-Rojas L, Rivero J, Rojas C, Jurado D. Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample. Prog Neuropsychopharmacol Biol Psychiatry 2012;37:169-175. https://doi.org/10.1016/j.pnpbp.2012.01.014
- Hohmann E, Brand JC, Rossi MJ, Lubowitz JH. Expert Opinion Is Necessary: Delphi Panel Methodology Facilitates a Scientific Approach to Consensus. Arthroscopy 2018;34:349-351. https://doi.org/10.1016/j.arthro.2017.11.022
- Salvador-Carulla L, Lukersmith S, Sullivan W. From the EBM pyramid to the Greek temple: a new conceptual approach to Guidelines as implementation tools in mental health. Epidemiol Psychiatr Sci 2017;26:105-114. https://doi.org/10.1017/S2045796016000767
- Kahn DA, Sachs GS, Printz DJ, Carpenter D, Docherty JP, Ross R. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines. J Psychiatr Pract 2000;6:197-211. https://doi.org/10.1097/00131746-200007000-00004
- Woo YS, Lee JG, Jeong JH, Kim MD, Sohn I, Shim SH, et al. Korean Medication Algorithm Project for Bipolar Disorder: third revision. Neuropsychiatr Dis Treat 2015;11:493-506.
- Reynolds GP, McGowan OO. Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment. J Psychopharmacol 2017;31:1430-1436. https://doi.org/10.1177/0269881117722987
- Argo TR, Carnahan RM, Perry PJ. Aripiprazole, a novel atypical antipsychotic drug. Pharmacotherapy 2004;24:212-228. https://doi.org/10.1592/phco.24.2.212.33145
- Kemp DE, Eudicone JM, McQuade RD, Chambers JS, Baker RA. Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a longterm, double-blind study in patients with bipolar disorder (CN138-010). J Clin Psychopharmacol 2010;30:631-634. https://doi.org/10.1097/JCP.0b013e3181f0569f
- Gupta S, Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry 2004;16:155-166. https://doi.org/10.1080/10401230490487007
- Daniel DG. Tolerability of ziprasidone: an expanding perspective. J Clin Psychiatry 2003;64 Suppl 19:40-49. https://doi.org/10.4088/JCP.v64n0109
- Musil R, Obermeier M, Russ P, Hamerle M. Weight gain and antipsychotics: a drug safety review. Expert Opin Drug Saf 2015;14:73-96. https://doi.org/10.1517/14740338.2015.974549
- Young SL, Taylor M, Lawrie SM. "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol 2015;29:353-362. https://doi.org/10.1177/0269881114562090
- Tondo L, Abramowicz M, Alda M, Bauer M, Bocchetta A, Bolzani L, et al. Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord 2017;5:27. https://doi.org/10.1186/s40345-017-0096-2
- Peselow ED, Clevenger S, IsHak WW. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study. Int Clin Psychopharmacol 2016;31:218-223. https://doi.org/10.1097/YIC.0000000000000097
- Kendall T, Morriss R, Mayo-Wilson E, Marcus E, Guideline Development Group of the National Institute for Health and Care Excellence. Assessment and management of bipolar disorder: summary of updated NICE guidance. BMJ 2014;349:g5673. https://doi.org/10.1136/bmj.g5673
- Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30:495-553. https://doi.org/10.1177/0269881116636545
- Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, et al. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINPBD-2017), Part 3: The Clinical Guidelines. Int J Neuropsychopharmacol 2017;20:180-195.
- Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20:97-170. https://doi.org/10.1111/bdi.12609